On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19

The present review summarizes up-to-date evidence addressing the frequently discussed clinical controversies regarding the use of immune checkpoint inhibitors (ICIs) in cancer patients with viral infections, including AIDS, hepatitis B and C, progressive multifocal leukoencephalopathy, influenza, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, Thilo, Reuther, Judith, Scheel, Christina H, Becker, Jürgen Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358098/
https://www.ncbi.nlm.nih.gov/pubmed/32611687
http://dx.doi.org/10.1136/jitc-2020-001145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358098/
https://www.ncbi.nlm.nih.gov/pubmed/32611687
http://dx.doi.org/10.1136/jitc-2020-001145

Ejemplares similares